Page 5 - Cell Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Stem Cells Market (2022-2027) by Product, Technology, Source, Applications, and Geography, with...

Equities research analysts expect Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) to announce earnings of ($0.31) per share for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Gamida Cell’s earnings. The lowest EPS estimate is ($0.32) and the highest is ($0.29). Gamida Cell posted earnings per share of ($0.42) in the […]

Shares of Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) have been assigned an average rating of “Buy” from the seven analysts that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price […]

Gamida Cell (NASDAQ:GMDA – Get Rating)‘s stock had its “buy” rating reaffirmed by stock analysts at JMP Securities in a note issued to investors on Thursday, TipRanks reports. They presently have a $17.00 price objective on the stock. A number of other equities analysts have also weighed in on GMDA. Zacks Investment Research lowered shares […]

Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 3,040,000 shares, a decline of 16.3% from the April 30th total of 3,630,000 shares. Currently, 7.3% of the company’s stock are sold short. Based on an average […]